Top Markets
#1 Nesa Nesa +337.52%
#2 EXOD EXOD +22.78%
#3 MetaDAO MetaDAO +14.79%
#4 Status Status +14.51%
#5 Wrapped NXM Wrapped NXM +7.60%
#6 PondCoin PondCoin +7.41%
#7 Kinesis Silver Kinesis Silver +6.73%
#8 Venom Venom +6.55%
#9 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +6.48%
#10 Ontology Gas Ontology Gas +5.41%
Coin of the day
Nesa Nesa
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Hyloris Pharmaceuticals S.A. Hyloris Pharmaceuticals S.A.

Hyloris Pharmaceuticals S.A.

HYL
Rang in Aktien #19946
Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and... Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and bringing to market pharmaceutical products designed to fulfill critical unmet medical needs. The company's focus areas include cardiovascular health, oncology, women's health, and other significant therapeutic domains. Its cardiovascular portfolio features treatments for conditions such as atrial fibrillation, acute coronary syndrome, advanced and congestive heart failure, and coronary heart disease. Beyond this, Hyloris addresses a diverse range of other ailments, including post-operative pain management, dental indications, severe and recurring vulvovaginal candidiasis, specific cancers (like acute myeloid leukemia and small cell lung cancer), interstitial cystitis/painful bladder syndrome (IC/PBS), attention deficit hyperactivity disorder (ADHD), and various viral infections. Established in 2012, Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.
Aktienkurs
$5.22
Zuletzt synchronisiert: 2026-08-25
Marktkapitalisierung
$146.14M
Veränderung (1 Tag)
-1.35%
Veränderung (1 Jahr)
-32.08%
Land
BE
Handel Hyloris Pharmaceuticals S.A. (HYL)

Kategorie

Healthcare
Kursverlauf für Hyloris Pharmaceuticals S.A. (HYL)
Höchster Schlusskurs: $5.35 am 2026-08-01

Niedrigster Schlusskurs: $11.76 am 2020-06-01
Kursverlauf der Aktie von Hyloris Pharmaceuticals S.A. von 2020 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -3.01%
2025 17.57%
2024 -54.17%
2023 -2.50%
2022 -29.03%
2021 58.84%
2020 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.07 -11.95%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 7.33%
CH